{
      "ptx_code": "PTX125",
      "chem_name": "5alpha-Dihydrotestosterone",
      "casrn": "521-18-6",
      "dtxsid": "DTXSID9022364",
      "smiles": "[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C",
      "inchikey": "NVKAWKQGWWIWPM-ABEVXSGRSA-N",
      "label": "PTX125 | 5alpha-Dihydrotestosterone",
      "drugbank_id": "DB02901",
      "use_class": "Endogenous",
      "tox_class": "Hepatotoxicity",
      "chem_name_user": "5alpha-Dihydrotestosterone",
      "mw_g_mol": "290.45",
      "solubility_h2o_mol_liter": "0.04",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "9.13e-10",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "7.43",
      "source_kaw": "LSER",
      "pka_acid": "15.99",
      "pka_base": "",
      "source_pka": "ACD pKa/GALAS",
      "log_kow_liter_liter": "3.55",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "3.71",
      "source_dlipw": "Kow-QSAR (\u2206mw=1)",
      "freely_dissolved_fraction": "0.25",
      "density_kg_liter": "",
      "source_density": "COMPTOX",
      "average_mass": "290.45",
      "boiling_point": "",
      "source_boiling_point": "",
      "melting_point": "181.0 \u00b0C",
      "source_melting_point": "Jean-Claude Bradley Open Melting Point Dataset",
      "vapor_pressure": "",
      "source_vapor_pressure": "",
      "baseline_drerio": "35.61",
      "baseline_dmagna": "31.25",
      "baseline_celegans": "69.02",
      "baseline_xlaevis": "42.19",
      "baseline_dmelanogaster": "266.76",
      "baseline_cells": "2.03e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "5.12e-06",
      "moa_drugbank": "",
      "protein_binding": "",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 57,
                  "AOP_name": "AhR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            }
      ],
      "targets": [
            "Androgen receptor",
            "Cytochrome P450 19A1",
            "Estradiol 17-beta-dehydrogenase 1",
            "Estrogen receptor alpha",
            "Estrogen receptor beta",
            "Glucocorticoid receptor",
            "Progesterone receptor"
      ]
}